vs

Side-by-side financial comparison of Orion Properties Inc. (ONL) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $36.3M, roughly 1.0× Orion Properties Inc.). On growth, Orion Properties Inc. posted the faster year-over-year revenue change (-4.6% vs -57.1%). Over the past eight quarters, Orion Properties Inc.'s revenue compounded faster (-4.9% CAGR vs -46.5%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

ONL vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.0× larger
ORGO
$37.2M
$36.3M
ONL
Growing faster (revenue YoY)
ONL
ONL
+52.5% gap
ONL
-4.6%
-57.1%
ORGO
Faster 2-yr revenue CAGR
ONL
ONL
Annualised
ONL
-4.9%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ONL
ONL
ORGO
ORGO
Revenue
$36.3M
$37.2M
Net Profit
$-13.6M
Gross Margin
30.8%
Operating Margin
-9.3%
-185.1%
Net Margin
-37.4%
Revenue YoY
-4.6%
-57.1%
Net Profit YoY
-45.0%
EPS (diluted)
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ONL
ONL
ORGO
ORGO
Q1 26
$36.3M
$37.2M
Q4 25
$35.2M
$225.6M
Q3 25
$37.1M
$150.9M
Q2 25
$37.3M
$101.0M
Q1 25
$38.0M
$86.7M
Q4 24
$38.4M
$126.7M
Q3 24
$39.2M
$115.2M
Q2 24
$40.1M
$130.2M
Net Profit
ONL
ONL
ORGO
ORGO
Q1 26
$-13.6M
Q4 25
$-35.8M
$43.7M
Q3 25
$-69.0M
$21.6M
Q2 25
$-25.1M
$-9.4M
Q1 25
$-9.4M
$-18.8M
Q4 24
$-32.8M
$7.7M
Q3 24
$-10.2M
$12.3M
Q2 24
$-33.8M
$-17.0M
Gross Margin
ONL
ONL
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
ONL
ONL
ORGO
ORGO
Q1 26
-9.3%
-185.1%
Q4 25
-101.5%
28.1%
Q3 25
-185.8%
13.7%
Q2 25
-67.1%
-12.5%
Q1 25
-24.4%
-30.9%
Q4 24
-85.4%
8.1%
Q3 24
-25.9%
5.4%
Q2 24
-84.1%
-10.7%
Net Margin
ONL
ONL
ORGO
ORGO
Q1 26
-37.4%
Q4 25
-101.7%
19.4%
Q3 25
-186.0%
14.3%
Q2 25
-67.3%
-9.3%
Q1 25
-24.6%
-21.7%
Q4 24
-85.4%
6.1%
Q3 24
-26.1%
10.7%
Q2 24
-84.2%
-13.1%
EPS (diluted)
ONL
ONL
ORGO
ORGO
Q1 26
$-0.24
Q4 25
$-0.63
$0.31
Q3 25
$-1.23
$0.11
Q2 25
$-0.45
$-0.10
Q1 25
$-0.17
$-0.17
Q4 24
$-0.59
$0.05
Q3 24
$-0.18
$0.09
Q2 24
$-0.60
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ONL
ONL
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$10.3M
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$608.5M
Total Assets
$1.2B
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ONL
ONL
ORGO
ORGO
Q1 26
$10.3M
$91.4M
Q4 25
$22.4M
$93.7M
Q3 25
$32.6M
$63.7M
Q2 25
$17.4M
$73.1M
Q1 25
$9.4M
$110.0M
Q4 24
$15.6M
$135.6M
Q3 24
$16.6M
$94.3M
Q2 24
$24.2M
$89.9M
Total Debt
ONL
ONL
ORGO
ORGO
Q1 26
Q4 25
$465.0M
Q3 25
$483.0M
Q2 25
$483.0M
Q1 25
$505.0M
Q4 24
$492.0M
Q3 24
$485.0M
$62.3M
Q2 24
$462.0M
$63.8M
Stockholders' Equity
ONL
ONL
ORGO
ORGO
Q1 26
$608.5M
Q4 25
$623.2M
$300.1M
Q3 25
$658.8M
$255.1M
Q2 25
$728.0M
$233.2M
Q1 25
$753.5M
$242.9M
Q4 24
$763.9M
$262.9M
Q3 24
$800.9M
$278.5M
Q2 24
$816.1M
$263.5M
Total Assets
ONL
ONL
ORGO
ORGO
Q1 26
$1.2B
$520.0M
Q4 25
$1.2B
$598.7M
Q3 25
$1.2B
$509.8M
Q2 25
$1.3B
$461.1M
Q1 25
$1.3B
$467.4M
Q4 24
$1.3B
$497.9M
Q3 24
$1.4B
$446.3M
Q2 24
$1.3B
$443.2M
Debt / Equity
ONL
ONL
ORGO
ORGO
Q1 26
Q4 25
0.75×
Q3 25
0.73×
Q2 25
0.66×
Q1 25
0.67×
Q4 24
0.64×
Q3 24
0.61×
0.22×
Q2 24
0.57×
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ONL
ONL

Rental$36.1M100%
Fee income from unconsolidated joint venture$137.0K0%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons